Skip to content
10-Q

Quarterly Report

BIO-PATH HOLDINGS, INC. BPTH

0001663577-26-000156

← back to feed
Filed
May 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 20, 2026 50.3M sh
Shares Diluted Q1 2026 · Mar 31, 2026 9.34M sh
Shares Diluted Q1 2026 · Mar 31, 2025 7.06M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$38K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.31M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$8.49M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$8.22M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$2.59M
Stockholders Equity Q1 2026 · Dec 31, 2024 $154K
Current Liabilities Q1 2026 · Mar 31, 2026 $9.15M
Current Liabilities Q1 2026 · Dec 31, 2025 $8.89M
Total Liabilities Q1 2026 · Mar 31, 2026 $9.16M
Total Liabilities Q1 2026 · Dec 31, 2025 $8.9M
Current Assets Q1 2026 · Mar 31, 2026 $677K
Current Assets Q1 2026 · Dec 31, 2025 $667K
Total Assets Q1 2026 · Mar 31, 2026 $677K
Total Assets Q1 2026 · Dec 31, 2025 $678K
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.03
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.40
Sga Expense Q1 2026 · Mar 31, 2026 $259K
Sga Expense Q1 2026 · Mar 31, 2025 $1.26M
Rd Expense Q1 2026 · Mar 31, 2026 $38K
Rd Expense Q1 2026 · Mar 31, 2025 $1.98M
Net Income Q1 2026 · Mar 31, 2026 −$270K
Net Income Q1 2026 · Mar 31, 2025 −$2.85M
Operating Income Q1 2026 · Mar 31, 2026 −$297K
Operating Income Q1 2026 · Mar 31, 2025 −$3.24M